Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II double-blind randomized trial of H008 (conorazant hydrochloride) tablets in duodenal ulcer
CTR20191638Phase 2Completed
- Sponsor
- Nanjing Kefei Ping Shenghui Pharmaceutical
- Start
- Aug 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of keverprazan in duodenal ulcer, sponsored by Nanjing Kefei Ping Shenghui Pharmaceutical. Started Aug 2019; status: completed.
02
Drugs
keverprazan
03
Conditions
duodenal ulcer
Beyond the preview
Go deeper on CTR20191638.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20191638.